Skip to content
OpenCapital
Get started

GeneDx Holdings WGS Market capitalization

Market capitalization at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$28.34B+48.3%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$8.08B-2.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$7.52B+10.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$21.53B+14.7%
Revvity logo
RevvityRVTY
$9.8B-22.9%
Labcorp Holdings logo
Labcorp HoldingsLH
$21.99B+12.9%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Enterprise value$1.73B-22.8%
P/S3.9×-3.0×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%—
Net margin-17.6%—
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%—
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Computed from the period-end share price: $1.88B.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GeneDx Holdings's market capitalization?
GeneDx Holdings (WGS) reported market capitalization of $1.88B in Q1 2026.
How has GeneDx Holdings's market capitalization changed year-over-year?
GeneDx Holdings's market capitalization decreased by 24.3% year-over-year, from $2.49B to $1.88B.
What is the long-term trend for GeneDx Holdings's market capitalization?
Over 4 years (2021 to 2025), GeneDx Holdings's market capitalization has grown at a -43.0% compound annual growth rate (CAGR), from $35.54B to $3.76B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.